SZSE: 000078 - Shenzhen Neptunus Bioengineering Co., Ltd.

Yield per half year: -14.17%
Dividend yield: 0.00%
Sector: Healthcare

Shenzhen Neptunus Bioengineering Co., Ltd.

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
1/10
577.59 69.4 732.28% 15.63 +3 595.32%
P/S 0.22 6.51 -96.62%
P/BV 1.81 3.96 -54.25%
P/FCF 0 0 0%
Ev/Ebitda 186.93 11.85 1477.67%
Ev/S 0.4566 5.98 -92.36%
Ev/FCF 0 0 0%
E/P -0.1185 0.0396 -399.29%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
1/10
1.91 16.34 -88.31% 3.91 -51.21%
ROE -14.49 11.95 -221.3%
ROA 1.25 5.4 -76.86%
ROIC 0 0 0%
ROS -2.64 16.23 -116.26%
ROCE 0 0 0%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
0/10
13.84 14.63 -5.36% 16.48 -15.98%
Nеt Debt/Ebitda 0 0 0%
Debt/Ratio 0 0 0%
Debt/Equity 0 0 0%
Debt/Net Income -12.1 3.6 -436.06%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 1.83 -100% 0.5331 -100%
Number of years of dividend growth 0 1.44 -100%
DSI 0.875 0.9113 -3.98%
Average dividend growth 11.81 10.4 13.64%
Average percentage for 5 years 0.5331 1.14 -53.32%
Average percentage for payments 262.63 44.8 486.22%
Difference from average difference in sector -1.83

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
0/10
-12.23 61.43 -119.91%
Growth impulse Ebitda in 5 years -82.82 158.62 -152.21%
Growth impulse Net Income in 5 years -801.33 66.93 -1297.27%
Growth impulse FCF in 5 years -124.48 248.41 -150.11%
Growth impulse EPS in 5 years 260.6 73.29 255.57%
IP Score
4/10

Similar companies

Shenzhen Neptunus Interlong Bio-technique Company Limited

Shenzhen Hepalink Pharmaceutical Group Co., Ltd.

Huadong Medicine Co., Ltd

Yunnan Baiyao Group Co.,Ltd

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription